Wells Fargo lowered the firm’s price target on KKR Real Estate Finance (KREF) to $11 from $14 and keeps an Overweight rating on the shares ...

KKR & Co. Inc. Q1 on May 1 could surprise positively amid strategic moves like the Biotage acquisition. Click here to see why KKR fundamentals offer long-term potential.

Citizens JMP lowered the firm’s price target on KKR Real Estate Finance (KREF) to $12 from $13 and keeps an Outperform rating on the shares.

We recently compiled a list of the 13 Best Aggressive Growth Stocks to Buy Now. In this article, we are going to take a look ...

KKR (KKR) is opting for direct lenders in financing its acquisition of Karo Healthcare, rather than banks it had chosen to ...

The firm, which has once again topped the latest AmLaw 100 ranking, has secured a series of sub-one billion dollar U.K. and ...

COPENHAGEN, April 22 (Reuters) - Sweden's Biotage (BIOT.ST), opens new tab said on Tuesday that KKR had made a cash offer for the Swedish biotechnology firm, valuing it at around 11.6 billion ...

The firm, which has once again topped the latest Am Law 100 ranking, has secured a series of sub-one billion dollar U.K. and ...

In this article, we are going to take a look at where KKR & Co. Inc. (NYSE:KKR) stands against Prem Watsa's other stock picks. Momentum and technology stocks have dominated the markets over the ...

(KREF) ...

Private equity firm KKR & Co. continued its spurt of acquisitions amid widespread market volatility by making a take-private offer for Swedish life sciences group Biotage AB for 11.6 billion ...

Private equity giant KKR is considering a partial exit from one of its Indian portfolio companies through a public market debut, after dropping its earlier plan for a secondary sale, three people ...